Hi there!

I wondered if anyone had any protocols or guidelines in your ambulatory spaces regarding monitoring / observation recommendations following administration of Omalizumab (Xolair®) in the outpatient or infusion center setting?

Thanks so much in advance,
Sincerely,

Emily